Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of the Ameliorated Pap Test on Cervical Cancer Screening Participation: a Multicenter Randomized Controlled Trial

NCT06968871 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT06968871
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06968871 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of the Ameliorated Pap Test on Cervical Cancer Screening Participation: a Multicenter Randomized Controlled Trial
Lead sponsor
National Taiwan University Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
March 1, 2026
Completion date
December 31, 2032
Enrollment
248 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer screening, cervical cancer screening methods